datamatters24/research-document-archive huggingface dataset:
Title II, Subtitle A
eral payment to the District of Columbia for the
year authorized under title V of the District of Co-
lumbia Self-Government and Governmental Reorga-
nization Act into an escrow account held by the Au-
thority, which shall allocate the funds to the Mayor
at such intervals and in accordance with such terms
and conditions as it considers appropriate to imple-
ment the financial plan for the year. In establishing
such terms and conditions, the Authority shall give
priority to using the Federal payment for cash flow
management and the payment of outstanding bills
owed by the District government.
(2) EXCEPTION FOR AMOUNTS WITHHELD FOR
ADVANCES.—Paragraph (1) shall not apply with re-
spect to any portion of the Federal payment which
is withheld by the Secretary of the Treasury in ac-
cordance with section 604 of title VI of the District
of Columbia Revenue Act of 1939 (as added by sec-
tion 204(c)) to reimburse the Secretary for advances
made under title VI of such Act.
(b) EXPENDITURE OF FUNDS FROM ACCOUNT IN AC-
CORDANCE
WITH
AUTHORITY
INSTRUCTIONS.—Any
funds allocated by the Authority to the Mayor from the
escrow account described in paragraph (1) may be ex-
pended by the Mayor only in accordance with the terms
‘‘(4) Funds made available under this subsection that
are not used by the State shall be available to the Sec-
retary for distribution to the States during the following
fiscal year, in accordance with procedures established by
the Secretary.
‘‘(5) The Secretary shall allow States to apply on an
annual basis for assistance under this subsection.
‘‘(6) In allocating funds within the State, each State
shall give preference for assistance under this subsection
to service institutions in areas that demonstrate the great-
est need for the program or that are in areas in which
poor economic conditions exist.
‘‘(7) Each State shall ensure that—
‘‘(A) service institutions receiving assistance
under this subsection establish additional feeding
sites that provide meal service to children in pre-
viously unserved areas; or
‘‘(B) as a result of receiving the assistance,
service institutions serve more meals than were
served in the previous year.
‘‘(8) Expenditures of funds from State and local
sources for the maintenance of the program shall not be
diminished as a result of payments received under this
subsection.
penses. Military travel expenses shall include 
travel expenses involving military combat, the 
training or deployment of uniformed military 
personnel, and such other travel expenses as de-
termined by the Director of the Office of Man-
agement and Budget, in consultation with the 
Administrator of General Services and the Di-
rector of the Administrative Office of the 
United States Courts. 
Passed the House of Representatives September 11, 
2012. 
Attest: 
Clerk.
112TH CONGRESS 
2D SESSION 
H. R. 4631 
AN ACT 
To amend title 5, United States Code, to institute 
spending limits and transparency requirements 
for Federal conference and travel expenditures, 
and for other purposes.
I 
112TH CONGRESS 
2D SESSION 
H. R. 4631 
To require quarterly reports on agency conferences and meetings, and for 
other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 25, 2012 
Mr. WALSH of Illinois (for himself, Mr. LONG, Mr. MICHAUD, and Mr. PAUL) 
introduced the following bill; which was referred to the Committee on 
Oversight and Government Reform 
A BILL 
To require quarterly reports on agency conferences and 
meetings, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Government Spending 
Accountability Act of 2012’’ or the ‘‘GSA Act of 2012’’. 
SEC. 2. AGENCY REPORTS ON CONFERENCES AND MEET-
INGS. 
(a) QUARTERLY REPORTS REQUIRED.—Not less fre-
quently than quarterly, the head of each agency shall sub-
mit a detailed, itemized report to the relevant committee 
VerDate Mar 15 2010 
20:33 Apr 27, 2012
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4631.IH
H4631
mstockstill on DSK4VPTVN1PROD with BILLS
‘‘(B) The materials shall inform State agencies about
the availability and importance of—
‘‘(i) the medicaid program to children from low-
income families, including a basic explanation of
program benefits and national income standards;
and
‘‘(ii) the medicaid program components estab-
lished for low-income elderly and disabled persons
under subparagraphs (A)(ii)(X) and (E) of section
1902(a)(10) of the Social Security Act (42 U.S.C.
1396a(a)(10)), including a basic explanation of pro-
gram benefits and national income standards.
‘‘(C) The Secretary—
‘‘(i) may request that the Secretary of Health
and Human Services assist in the preparation of the
materials; and
‘‘(ii) shall submit the materials to the Secretary
of Health and Human Services for comment prior to
submitting the materials to State agencies.
‘‘(2) The Secretary shall also provide State agencies
with basic information concerning the importance and
benefits of the special nutrition program for women, in-
fants, and children authorized under section 17 of the
Child Nutrition Act of 1966 (42 U.S.C. 1786).
‘‘(3) The State agency shall—
of Congress on any conference or meeting that occurs at 
a location for which the agency must pay a fee or at a 
location not owned, leased, or otherwise controlled by the 
Federal Government and— 
(1) that is attended by 50 or more employees; 
or 
(2) for which the total cost is $100,000 or 
more. 
(b) EXCLUSIONS.—Subsection (a) shall not apply 
with respect to any conference or meeting that the head 
of an agency determines— 
(1) that reporting on such conference or meet-
ing would not be in the interest of national security; 
or 
(2) is necessary because of an imminent threat 
to health or safety or other emergency. 
(c) DEFINITIONS.—In this section: 
(1) AGENCY.—The term ‘‘agency’’ has the 
meaning given that term in section 551 of title 5, 
United States Code. 
(2) EMPLOYEE.—The term ‘‘employee’’ has the 
meaning given that term in section 2105 of title 5, 
United States Code. 
Æ 
VerDate Mar 15 2010 
20:33 Apr 27, 2012
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H4631.IH
H4631
mstockstill on DSK4VPTVN1PROD with BILLS
I
103D CONGRESS
1ST SESSION
H. R. 3576
To clarify the tariff classification of certain organo-phosphorous compounds
and preparations thereof.
IN THE HOUSE OF REPRESENTATIVES
NOVEMBER 19, 1993
Mr. TAUZIN introduced the following bill; which was referred to the Committee
on Ways and Means
A BILL
To clarify the tariff classification of certain organo-
phosphorous compounds and preparations thereof.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 
1. 
CERTAIN 
ORGANO-PHOSPHOROUS 
COM-
POUNDS.
Chapter 29 of the Harmonized Tariff Schedule of the
United States is amended by striking subheading
2931.00.50 and inserting in numerical sequence the fol-
lowing new superior text and subheadings, with the article
description for subheading 2931.00.45 having the same
degree of indentation as the article description in sub-
heading 2931.00.10:
‘‘
Other:
2931.00.45
N-(Phosphonomethyl)glycine;
Phosphonomethyliminodiacetic acid;
Aminomethane phosphonic acid; and
their salts and esters ........................
12.5%
Free
(E,IL,CA)
15.4¢/kg +
68%
2931.00.55
Other ................................................
3.7%
Free (A*,CA,
E,IL,J)
25%
’’.
SEC. 2. PREPARATIONS CONTAINING CERTAIN ORGANO-
PHOSPHOROUS COMPOUNDS.
Chapter 38 of the Harmonized Tariff Schedule of the
United States is amended by inserting in numerical se-
quence the following new superior text and subheading,
with the article description having the same indentation
as the article description in subheading 3808.30.20:
‘‘
Other:
3808.30.15
Containing 
N-
(phosphonomethyl)glycine 
or 
its
salts or esters ...................................
12.5%
Free
(E,CA,IL)
15.4¢/kg +
68%
’’.
SEC. 3. APPLICABILITY.
The amendments made by sections 1 and 2 shall
apply with respect to goods entered, or withdrawn from
warehouse for consumption, on or after the date of the
enactment of this Act.
Æ
I 
112TH CONGRESS 
2D SESSION 
H. R. 4632 
To extend the suspension of duty on 2-Chlorotoluene. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 25, 2012 
Mr. ALTMIRE introduced the following bill; which was referred to the 
Committee on Ways and Means 
A BILL 
To extend the suspension of duty on 2-Chlorotoluene. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. 2-CHLOROTOLUENE. 
(a) IN GENERAL.—Heading 9902.22.17 of the Har-
monized Tariff Schedule of the United States (relating to 
2-Chlorotoluene) is amended by striking the date in the 
effective period column and inserting ‘‘12/31/2015’’. 
(b) EFFECTIVE DATE.—The amendment made by 
this section applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ 
VerDate Mar 15 2010 
01:59 May 03, 2012
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6301
E:\BILLS\H4632.IH
H4632
tjames on DSK6SPTVN1PROD with BILLS
I
103D CONGRESS
1ST SESSION
H. R. 3577
To establish a Center for Rare Disease Research in the National Institutes
of Health, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
NOVEMBER 19, 1993
Mr. WASHINGTON (for himself, Mr. FRANKS of Connecticut, and Mr. TOWNS)
introduced the following bill; which was referred to the Committee on En-
ergy and Commerce
A BILL
To establish a Center for Rare Disease Research in the
National Institutes of Health, and for other purposes.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ‘‘Center for Rare Dis-
ease Research Act of 1993’’.
SEC. 2. ESTABLISHMENT OF CENTER FOR RARE DISEASE
RESEARCH.
Part E of title IV of the Public Health Service Act
(42 U.S.C. 287 et seq.) is amended by adding at the end
thereof the following new subpart:
‘‘Subpart 4—Center for Rare Disease Research
‘‘SEC. 485C. ESTABLISHMENT.
‘‘(a) IN GENERAL.—There shall be established in the
Office of the Director of the National Institutes of Health
a Center for Rare Disease Research (hereafter referred
to in this section as the ‘Center’). The Director of the Na-
tional Institutes of Health shall appoint an individual with
expertise in rare diseases to serve as the Director of
the Center (hereafter referred to in this section as the
‘Director’).
‘‘(b) PURPOSE.—The general purpose of the Center
is to promote and coordinate the conduct of research on
rare diseases and to establish and manage a rare disease
research clinical database. In carrying out the purpose of
the Center, the Director shall—
‘‘(1) conduct and support research and research
training;
‘‘(2) award grants and contracts;
‘‘(3) identify projects of research on rare dis-
eases that should be conducted or supported by the
National Institutes of Health;
‘‘(4) disseminate information among the insti-
tutes and the public on rare diseases;
‘‘(5) develop and maintain a central database
on current clinical research projects for rare dis-
eases;
‘‘(6) encourage the participation of a diversity
of individuals in the conduct of rare disease re-
search; and
‘‘(7) coordinate the conduct of rare disease re-
search among all institutes and other Federal agen-
cies.
‘‘(c) STRATEGIC RESEARCH PLAN.—The Director
shall develop a comprehensive plan for the conduct and
support of research on rare diseases. The plan shall—
‘‘(1) identify current research activities con-
ducted or supported by the Federal Government and
private entities, opportunities and needs for addi-
tional research and priorities for such research;
‘‘(2) make recommendations for the improved
coordination of research conducted by the Federal
Government among its agencies and private entities;
‘‘(3) give emphasis to areas with respect to
which little research has been conducted;
‘‘(4) examine the extent of research on gene
therapy and genetic transfers and develop a plan to
enhance the extent of research on gene therapy, par-
ticularly for rare diseases;
‘‘(5) determine the need for registries of re-
search subjects and epidemiological studies of rare
disease populations;
I 
112TH CONGRESS 
2D SESSION 
H. R. 4635 
To extend the suspension of duty on Phenylisocyanate. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 25, 2012 
Mr. ALTMIRE introduced the following bill; which was referred to the 
Committee on Ways and Means 
A BILL 
To extend the suspension of duty on Phenylisocyanate. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. PHENYLISOCYANATE. 
(a) IN GENERAL.—Heading 9902.02.14 of the Har-
monized Tariff Schedule of the United States (relating to 
Phenylisocyanate) is amended by striking the date in the 
effective period column and inserting ‘‘12/31/2015’’. 
(b) EFFECTIVE DATE.—The amendment made by 
this section applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ 
VerDate Mar 15 2010 
01:59 May 03, 2012
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6301
E:\BILLS\H4635.IH
H4635
tjames on DSK6SPTVN1PROD with BILLS
I 
112TH CONGRESS 
2D SESSION 
H. R. 4633 
To extend the suspension of duty on Chloromethylbenzene. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 25, 2012 
Mr. ALTMIRE introduced the following bill; which was referred to the 
Committee on Ways and Means 
A BILL 
To extend the suspension of duty on Chloromethylbenzene. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. CHLOROMETHYLBENZENE. 
(a) IN GENERAL.—Heading 9902.22.18 of the Har-
monized Tariff Schedule of the United States (relating to 
Chloromethylbenzene) is amended by striking the date in 
the effective period column and inserting ‘‘12/31/2015’’. 
(b) EFFECTIVE DATE.—The amendment made by 
this section applies to goods entered, or withdrawn from 
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ 
VerDate Mar 15 2010 
01:59 May 03, 2012
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6301
E:\BILLS\H4633.IH
H4633
tjames on DSK6SPTVN1PROD with BILLS
I
103D CONGRESS
1ST SESSION
H. R. 3578
To authorize appropriations for the California Afro-American Museum.
IN THE HOUSE OF REPRESENTATIVES
NOVEMBER 19, 1993
Ms. WATERS introduced the following bill; which was referred to the
Committee on Natural Resources
A BILL
To authorize appropriations for the California Afro-American
Museum.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. FINDINGS.
The Congress finds the following:
(1) The California Afro-American Museum is
among the most important cultural centers in Amer-
ica dedicated to the contributions of African-Ameri-
cans to the growth and westward expansion of
America.
(2) The California Afro-American Museum pre-
serves, collects, and displays African-American con-
tributions to the arts, science, religion, education,
literature, entertainment, politics, sports, and his-
tory of the State and the Nation.
(3) The California Afro-American Museum is
located in historical Exposition Park, the venue of
the 1932 and 1984 Olympic Games, together with
the Coliseum, Rose Garden, and Natural History
Museum which are historical landmarks.
(4) The California Afro-American Museum
houses 3 galleries, a 13,000 square foot sculpture
court, multi-purpose room, 99-seat theater, as well
as a 60,000 volume research library. Attendance has
increased dramatically over the last 5 years with an
annual rise of approximately 20,000.
(5) The lack of a comprehensive, local context
within which to interpret African-American history
and culture impedes the ability of all Americans,
particularly African-Americans, to understand them-
selves and their relationship to America’s past and
its future.
(6) The continued existence of a museum on
African-American history and culture, which will in-
clude a wide array of collections from an eclectic
group of African-Americans, will help all Americans,
and those who visit our country from abroad, better
understand and appreciate the significant contribu-
tions made by African-Americans to American as
well as world history.
SEC. 2. AUTHORIZATION OF APPROPRIATIONS.
(a) AMOUNT.—There are authorized to be appro-
priated $2,000,000 to the Secretary of the Interior for fis-
cal year 1995 to sustain the California Afro-American Mu-
seum.
(b) AVAILABILITY OF FUNDS.—Funds appropriated
pursuant to subsection (a) are authorized to remain avail-
able until expended.
Æ
I 
112TH CONGRESS 
2D SESSION 
H. R. 4634 
To extend the suspension of duty on 2,3-Dichloronitrobenzene. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 25, 2012 
Mr. ALTMIRE introduced the following bill; which was referred to the 
Committee on Ways and Means 
A BILL 
To extend the suspension of duty on 2,3- 
Dichloronitrobenzene. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. 2,3-DICHLORONITROBENZENE. 
(a) IN GENERAL.—Heading 9902.22.20 of the Har-
monized Tariff Schedule of the United States (relating to 
2,3-Dichloronitrobenzene) is amended by striking the date 
in the effective period column and inserting ‘‘12/31/2015’’. 
(b) EFFECTIVE DATE.—The amendment made by 
this section applies to goods entered, or withdrawn from 
VerDate Mar 15 2010 
01:59 May 03, 2012
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4634.IH
H4634
tjames on DSK6SPTVN1PROD with BILLS
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ 
VerDate Mar 15 2010 
01:59 May 03, 2012
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H4634.IH
H4634
tjames on DSK6SPTVN1PROD with BILLS
V
103D CONGRESS
1ST SESSION
H. R. 3579
To renew and extend patents relating to certain devices that aid in the
acceleration of bodily tissue healing and the reduction of pain.
IN THE HOUSE OF REPRESENTATIVES
NOVEMBER 19, 1993
Mr. ACKERMAN introduced the following bill; which was referred to the
Committee on the Judiciary
A BILL
To renew and extend patents relating to certain devices
that aid in the acceleration of bodily tissue healing and
the reduction of pain.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. EXTENSION OF PATENT.
The Secretary of Commerce, acting through the Com-
missioner of Patents and Trademarks, shall, when the pat-
ent numbered 4,226,246 (relating to an apparatus for
maintaining the negative potential of human, animal, and
plant cells) expires, extend the patent, with all the rights
pertaining thereto, for a period of 10 years beginning on
the date of the patent’s expiration.
SEC. 2. RENEWAL AND EXTENSION OF PATENTS.
(a) RENEWAL AND EXTENSION.—The Secretary of
Commerce, acting through the Commissioner of Patents,
shall renew and extend each of the patents described in
subsection (b), with all the rights pertaining thereto, for
a period of 10 years beginning on the date of the patent’s
renewal and extension. The Secretary shall take the ac-
tions required by this section as soon as possible, but not
later than 60 days after the date of the enactment of this
Act.
(b) DESCRIPTION OF PATENTS.—Subsection (a) shall
apply to the patents bearing the following numbers:
(1) 3,670,737 (relating to an ultra-short wave
athermapeutic (non-thermal pulsed high-peak high-
frequency electromagnetic energy) apparatus).
(2) 3,566,877 (relating to an electrotherma-
peutic apparatus and treatment head, and method
for tuning the treatment head).
(3) 3,464,010 (relating to a power meter for an
athermapeutic apparatus).
(4) 3,181,535 (relating to an athermapeutic ap-
paratus).
(5) 3,043,310 (relating to a treatment head for
an athermapeutic apparatus).
(c) INTERVENING RIGHTS.—The renewal and exten-
sion of the patents described in subsection (b) shall not
result in infringement of any of the patents on account
of any use of the subject matter of the patent, or substan-
tial preparation for such use, that began after the patent
expired but before the date of the enactment of this Act.
Æ
I
103D CONGRESS
1ST SESSION
H. R. 357
To amend the Internal Revenue Code of 1986 to provide that the one-
time exclusion of gain from sale of a principal residence shall apply
to a portion of the farmland on which the residence is located.
IN THE HOUSE OF REPRESENTATIVES
JANUARY 5, 1993
Mr. SLATTERY introduced the following bill; which was referred to the
Committee on Ways and Means
A BILL
To amend the Internal Revenue Code of 1986 to provide
that the one-time exclusion of gain from sale of a prin-
cipal residence shall apply to a portion of the farmland
on which the residence is located.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. TREATMENT OF FARMLAND SOLD WITH RESI-
DENCE UNDER ONE-TIME EXCLUSION OF
GAIN FROM SALE OF PRINCIPAL RESIDENCE.
(a) IN GENERAL.—Subsection (d) of section 121 of
the Internal Revenue Code of 1986 (relating to one-time
exclusion of gain from sale of principal residence by indi-
vidual who has attained age 55) is amended by adding
at the end thereof the following new paragraph:
‘‘(10) TREATMENT OF FARMLAND SOLD WITH
RESIDENCE.—If—
‘‘(A) a parcel of farmland on which is lo-
cated a residence with respect to which the tax-
payer meets the holding and use requirements
of subsection (a) is sold with such residence,
‘‘(B) the taxpayer meets the holding re-
quirements of subsection (a) with respect to
such farmland, and
‘‘(C) the taxpayer meets requirements
similar 
to 
the 
requirements 
of 
section
2032A(b)(1)(C) with respect to such farmland,
notwithstanding paragraph (5), the taxpayer shall be
treated as meeting the use requirements of sub-
section (a) with respect to so much of such parcel
as does not exceed 160 acres and with respect to
structures thereon.’’
(b) EFFECTIVE DATE.—The amendment made by
this section shall apply to sales or exchanges after Decem-
ber 31, 1992.
Æ
I 
112TH CONGRESS 
2D SESSION 
H. R. 4636 
To extend the suspension of duty on certain ethylene-vinyl acetate copolymers. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 25, 2012 
Mr. ALTMIRE introduced the following bill; which was referred to the 
Committee on Ways and Means 
A BILL 
To extend the suspension of duty on certain ethylene-vinyl 
acetate copolymers. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. CERTAIN ETHYLENE-VINYL ACETATE COPOLY-
MERS. 
(a) IN GENERAL.—Heading 9902.24.55 of the Har-
monized Tariff Schedule of the United States (relating to 
certain ethylene-vinyl acetate copolymers) is amended by 
striking the date in the effective period column and insert-
ing ‘‘12/31/2015’’. 
(b) EFFECTIVE DATE.—The amendment made by 
this section applies to goods entered, or withdrawn from 
VerDate Mar 15 2010 
01:59 May 03, 2012
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4636.IH
H4636
tjames on DSK6SPTVN1PROD with BILLS
warehouse for consumption, on or after the 15th day after 
the date of the enactment of this Act. 
Æ 
VerDate Mar 15 2010 
01:59 May 03, 2012
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H4636.IH
H4636
tjames on DSK6SPTVN1PROD with BILLS